RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 New Insulin Glargine Formulation Associated with Less Nocturnal Hypoglycemia
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 17
SP 25
OP 26
DO 10.1177/155989771317017
UL http://mdc.sagepub.com/content/13/17/25.abstract
AB A long-acting basal insulin glargine formulation, 300 U/mL (Gla-300), controlled glycemia as well as insulin glargine 100 U/mL (Gla-100) in patients with type 2 diabetes mellitus (T2DM) but with less nocturnal hypoglycemia. This article presents findings from a Phase 3 multicenter, open-label [EDITION I; NCT01499082] study comparing the two insulin glargine formulations in patients with T2DM who were using basal plus mealtime insulin.